Epicardial adipose tissue has unique properties that distinguish it from other depots of
visceral fat. Rather than having distinct boundaries, the epicardium shares an unobstructed …

Accumulating evidence points to the existence of an inflammatory‐metabolic phenotype of
heart failure with a preserved ejection fraction (HFpEF), which is characterized by …

Obesity (especially visceral adiposity) can be associated with 3 different phenotypes of heart
failure: heart failure with a reduced ejection fraction, heart failure with a preserved ejection …

Among patients with heart failure and a preserved ejection (HFpEF), obesity is associated
with a distinct phenotype that is characterized by adiposity‐driven plasma volume expansion …

Background Epicardial adipose tissue (EAT) has been suggested to exert deleterious effects
on myocardium and cardiovascular disease (CVD) consequence. We evaluated the …

Abstract Purpose of Review Heart failure (HF) continues to be a public health burden
despite advances in therapy, and the natriuretic peptide (NP) system is clearly of critical …

Background/Objectives Obesity is believed to be one of the major risk factors for
cardiovascular disease in Western countries. However, the effects of obesity should be …

Levels of natriuretic peptides (NPs), such as B-type NP (BNP) and the N-terminal fragment of
its prohormone (NT-proBNP), are well-established biomarkers for patients with heart failure …

B-type natriuretic peptide (BNP) is widely used as a diagnostic marker of systolic
dysfunction. We previously conducted a clinical study in which anthracycline or …

Importance Despite their clinical benefits, mineralocorticoid receptor antagonists are greatly
underprescribed by most practitioners who treat patients with chronic heart failure. A novel …